定性3-T质子磁共振波谱用于肌肉骨骼肿瘤表征:诊断性能与适应证的更新
该前瞻性研究纳入74例患者76个经组织学证实的肌肉骨骼肿瘤,在3-T MRI上行质子磁共振波谱,视觉评估3.2 ppm处胆碱峰有无,以胆碱峰存在提示恶性。两种软件诊断性能相似(κ=0.97);定性1H-MRS无法鉴别良恶性骨肿瘤(最佳敏感度50.0%、特异度61.5%),对软组织病变敏感度较好但特异度仍低(最佳敏感度82.4%、特异度64.3%),应用谱质标准时排除35.4%的软组织谱。结论:定性3-T 1H-MRS不能用于骨肿瘤表征,对软组织病变敏感度高但特异度低。
要点
- 定性3-T 1H-MRS以3.2 ppm胆碱峰存在提示恶性,不能用于骨肿瘤良恶性鉴别。
- 对软组织病变最佳敏感度82.4%、特异度64.3%,特异度仍低。
- 应用谱质标准评估软组织肿瘤时排除35.4%的谱。
核心结论
- 定性3-T 1H-MRS不能用于骨肿瘤的表征。
- 该技术对软组织病变表征有良好敏感度但特异度低。
研究设计与样本
- 前瞻性纳入74例患者76个经组织学证实的肌肉骨骼肿瘤,使用3-T MRI扫描仪行质子磁共振波谱。
- 谱分别用设备厂商提供的常规MRI软件和专用独立MRS软件分析,视觉评估3.2 ppm处胆碱峰有无,以胆碱峰存在提示恶性。
- 考虑肿瘤来源和谱质量对诊断性能的影响。
关键影像表现/征象
- 视觉评估3.2 ppm处胆碱峰的有无,以胆碱峰存在提示恶性。
诊断标准与关键数值
- 骨肿瘤:无论是否应用质量 criteria,定性1H-MRS均不能鉴别良恶性,最佳敏感度50.0%、特异度61.5%。
- 软组织病变:最佳敏感度82.4%、特异度64.3%。
- 两种软件诊断性能相似(κ=0.97)。
- 应用谱质标准评估软组织肿瘤时排除35.4%的受评估谱。
临床应用与阅片要点
- 定性3-T 1H-MRS不能用于骨肿瘤表征。
- 对软组织病变该技术有良好敏感度但特异度低。
局限性
- 定性3-T 1H-MRS对软组织病变特异度仍低(最佳特异度64.3%)。
- 应用谱质标准评估软组织肿瘤时排除35.4%的受评估谱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of our study was to evaluate the diagnostic performance of qualitative 3-T proton MR spectroscopy (1H-MRS) for the characterization of musculoskeletal neoplasms.
SUBJECTS AND METHODS: Proton MRS studies of 74 patients (76 lesions) with a histologically confirmed musculoskeletal neoplasm or neoplasms were prospectively included in this study. All studies were performed using a 3-T MRI scanner. Spectra were analyzed with conventional MRI software provided by the fabricant and with dedicated independent MRS software. Spectra were evaluated visually for the presence or absence of a choline peak at 3.2 ppm. The presence of a choline peak was considered indicative of malignancy. The influences of tumor origin and spectral quality on diagnostic performance were considered.
RESULTS: Diagnostic performance was similar with both software used (κ = 0.97). Qualitative 1H-MRS failed to differentiate benign from malignant bone tumors regardless of the application of quality criteria (best sensitivity and specificity, 50.0% and 61.5%, respectively). Diagnostic performance was better with soft-tissue lesions, but the specificity remained low (best sensitivity and specificity, 82.4% and 64.3%, respectively). The application of spectral quality criteria for the evaluation of soft-tissue tumors led to the exclusion of 35.4% of the evaluated spectra.
CONCLUSION: Qualitative 3-T 1H-MRS cannot be used to characterize bone tumors. This technique has good sensitivity but poor specificity for the characterization of soft-tissue lesions.
引用
- Gondim Teixeira PA, Ledrich M, Kauffmann F, et al. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications. AJR Am J Roentgenol. 2017. PMID: 28301222. doi:10.2214/AJR.16.17285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。